Chen M F, Chen L T, Boyce H W
Department of Internal Medicine, University of South Florida College of Medicine, Tampa 33612-4799.
Cancer Lett. 1995 Jan 27;88(2):133-40. doi: 10.1016/0304-3835(94)03628-v.
Exposure of the human colon adenocarcinoma HT29 cells to different concentrations of 5-fluorouracil (5FU) for 24 h resulted in a dose-dependent increase in the cellular glutathione (GSH) level which remained elevated up to 72 h following 5FU treatment. Pretreatment of HT29 cells with 5FU was found to enhance the uptake of methotrexate (MTX) as compared to control cells. Administration of MTX 24 h after 5FU was found to be synergistic, whereas administration of MTX 24 h before 5FU or together with 5FU was not found to be synergistic. The results of this study suggest that the increase in cellular GSH level as a result of 5FU pretreatment may play a role in the enhancement of MTX uptake and the cytotoxicity of both drugs in HT29 cells.
将人结肠腺癌HT29细胞暴露于不同浓度的5-氟尿嘧啶(5FU)中24小时,导致细胞内谷胱甘肽(GSH)水平呈剂量依赖性增加,在5FU处理后直至72小时该水平仍保持升高。与对照细胞相比,发现用5FU预处理HT29细胞可增强甲氨蝶呤(MTX)的摄取。在5FU处理24小时后给予MTX具有协同作用,而在5FU处理前24小时或与5FU同时给予MTX则未发现具有协同作用。本研究结果表明,5FU预处理导致的细胞GSH水平升高可能在增强MTX摄取以及两种药物对HT29细胞的细胞毒性中发挥作用。